Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via β3AR/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia

PLoS One. 2015 Jul 1;10(7):e0131923. doi: 10.1371/journal.pone.0131923. eCollection 2015.

Abstract

Chronic intermittent hypoxia (IH) induces activation of the sympathoadrenal system, which plays a pivotal role in attenuating hypoxic pulmonary vasoconstriction (HPV) via central β1-adrenergic receptors (AR) (brain) and peripheral β2AR (pulmonary arteries). Prolonged hypercatecholemia has been shown to upregulate β3AR. However, the relationship between IH and β3AR in the modification of HPV is unknown. It has been observed that chronic stimulation of β3AR upregulates inducible nitric oxide synthase (iNOS) in cardiomyocytes and that IH exposure causes expression of iNOS in RAW264.7 macrophages. iNOS has been shown to have the ability to dilate pulmonary vessels. Hence, we hypothesized that chronic IH activates β3AR/iNOS signaling in pulmonary macrophages, leading to the promotion of NO secretion and attenuated HPV. Sprague-Dawley rats were exposed to IH (3-min periods of 4-21% O2) for 8 h/d for 6 weeks. The urinary catecholamine concentrations of IH rats were high compared with those of controls, indicating activation of the sympathoadrenal system following chronic IH. Interestingly, chronic IH induced the migration of circulating monocytes into the lungs and the predominant increase in the number of pro-inflammatory pulmonary macrophages. In these macrophages, both β3AR and iNOS were upregulated and stimulation of the β3AR/iNOS pathway in vitro caused them to promote NO secretion. Furthermore, in vivo synchrotron radiation microangiography showed that HPV was significantly attenuated in IH rats and the attenuated HPV was fully restored by blockade of β3AR/iNOS pathway or depletion of pulmonary macrophages. These results suggest that circulating monocyte-derived pulmonary macrophages attenuate HPV via activation of β3AR/iNOS signaling in chronic IH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hypertension, Pulmonary / metabolism
  • Hypoxia / metabolism*
  • Lung / metabolism*
  • Macrophages, Alveolar / metabolism*
  • Myocytes, Cardiac / metabolism
  • Nitric Oxide Synthase Type II / metabolism*
  • Pulmonary Artery / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstriction / physiology

Substances

  • Nitric Oxide Synthase Type II

Grants and funding

This study was mainly supported by Grants-in-Aid for Scientific Research (No. 23249038 and 23590843) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), and was also supported in part by the Intramural Research Fund (22-2-3, 25-3-1) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center (http://www.ncvc.go.jp/english/) and Grants-in Aid for Scientific Research (No. 23650213, 24790863, 26670413 and 24·2221) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.